Zoll Circulation, Inc.
USPTO PatentsView assignee record - 143 granted patents across 27 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Zoll ranks #2,718 of 49,997 tracked US assignees by granted-patent volume, with 143 patents across 27 technology areas.
- #2,718
- of 49,997 US assignees by volume
- Top 12%
- by Innovation Score (51.3/100)
- 15.7
- avg claims per patent
- -14%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R2718 · US Corporation #2,718 · 143 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MID 143 grants
- TOP-DECILE #2,718/49,997
- PHOTO-FINISH STMicroelectronics…
- CPC-FOCUS A61F · 27 areas
- INNOV-PAR 51.3/100
- CLAIMS-RICH 15.7 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -14% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: STMicroelectronics (Alps) SAS (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Zoll’s 51.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Zoll
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Bard Peripheral… · near
Bard Peripheral… · near
51 score
- Guardian Industries · near
Guardian Industries · near
51 score
- Hill's Pet Nutrition · near
Hill's Pet Nutrition · near
51 score
- iLOQ Oy · near
iLOQ Oy · near
51 score
- Zoll Circulation · this assignee
Zoll Circulation · this assignee
51 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Zoll's Innovation Score is 51.3/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Zoll?
Each dot is one of Zoll’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Zoll’s own 15.7 claims/patent is at or below the 17.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Zoll's grants concentrate
Zoll Circulation, Inc. is a focused PatentsView assignee: 27 CPC subclasses with 60.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (28 grants) versus a trough of 7 in 2021. By volume, Zoll sits between STMicroelectronics (Alps) SAS and Fondazione Istituto Italiano DI Tecnologia.
Zoll's three-year grant acceleration
From 2019–2021 to 2022–2024, Zoll Circulation, Inc. moved from 37 to 35 grants (0.95x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,339. See the growth leaderboard.
Who files at Zoll's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Stmicroelectronic…
STMicroelectronics (Alps) SAS
143 patents
- Taiwan FU Hsing I…
Taiwan FU Hsing Industrial Co., Ltd.
143 patents
- Teleflex Medical…
Teleflex Medical Incorporated
143 patents
- Tele Tracking
Tele Tracking Technologies, Inc.
143 patents
- Zoll Circulation ◀
Zoll Circulation, Inc.
143 patents
- Coopervision Inte…
Coopervision International Limited
142 patents
- Cohere
Cohere Technologies, Inc.
142 patents
- DTS
DTS, Inc.
142 patents
- Fondazione Istitu…
Fondazione Istituto Italiano DI Tecnologia
142 patents
What this shows Zoll holds 143 patents at rank #2,718, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Zoll
By rank, the assignees closest to #2,718 in granted patent volume.
- STMicroelectronics (Alps) SAS #2,714 · 143 patents
- Taiwan FU Hsing Industrial Co., Ltd. #2,715 · 143 patents
- Teleflex Medical Incorporated #2,716 · 143 patents
- Tele Tracking Technologies, Inc. #2,717 · 143 patents
- Coopervision International Limited #2,719 · 142 patents
- Cohere Technologies, Inc. #2,720 · 142 patents
- DTS, Inc. #2,721 · 142 patents
- Fondazione Istituto Italiano DI Tecnologia #2,722 · 142 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Zoll's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Zoll, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Zoll ranks #66 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (51 here).
Similar claim depth
Nearest assignees by average claims per patent (15.7 here).
Zoll's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 10 | 7.0% |
| 2016 | 28 | 19.6% |
| 2017 | 16 | 11.2% |
| 2018 | 10 | 7.0% |
| 2019 | 9 | 6.3% |
| 2020 | 21 | 14.7% |
| 2021 | 7 | 4.9% |
| 2022 | 12 | 8.4% |
| 2023 | 11 | 7.7% |
| 2024 | 12 | 8.4% |
| 2025partial year | 7 | 4.9% |
Which technologies does Zoll Circulation, Inc. patent most?
Top 15 of 27 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Zoll Circulation, Inc.'s patent record in context - here's where to go next.
- Zoll Circulation, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 60.1% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #2,718 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Zoll Circulation, Inc. against STMicroelectronics (Alps) SAS, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 51.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.